Press Release: Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation

About this update from Sanofi Sa

[{"type":"image","alt":"Sanofi Winthrop Industrie","displaySize":"","headline":null,"caption":"Sanofi Winthrop Industrie","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":84,"url":"https://media.zenfs.com/en/globenewswire.com/c45c40f5ed741dd9c0f5c2f75b8fc137"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/njIuMc8eT.GfUOY8hGPCUA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExODtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/c45c40f5ed741dd9c0f5c2f75b8fc137","width":300,"height":84}},"lazy":false},{"type":"text","content":"Sanofi reaches agreement with the US government to lower medicine costs while strengthening innovation","length":102,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Agreement delivers on President Trump’s four requests, establishing a framework for lower prices for patients in the US and a tariff-free accord for Sanofi","length":155,"tagName":"p"}]},{"val":[{"type":"text","content":"Showcases commitment to US manufacturing, innovation, and economic growth","length":73,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":228,"olType":false},{"type":"text","content":"Paris, December 19, 2025. Sanofi today announced an agreement with President Donald J. Trump's Administration to help ensure American patients have access to more affordable medicines while also supporting the role of the US in biopharmaceutical manufacturing and innovation. With this agreement, Sanofi confirms its growth strategy to take the lead through breakthrough science and by striving to be a driver of progress and positive impact for the people and communities it serves.","length":487,"tagName":"p"},{"type":"text","content":"The voluntary, confidential agreement reached with President Trump and members of his Administration meets all four requests outlined in the President's July 31, 2025, letter while establishing a sustainable framework for continued US leadership in scientific research and development.","length":289,"tagName":"p"},{"type":"text","content":"This agreement will ensure state Medicaid programs can access certain Sanofi medicines at the same prices available to other high-income nations. This will reduce prices by an average of 61 percent for certain medicines that treat diabetes, cardiovascular and neurological conditions and cancer. Sanofi also will offer consumers access ...

More updates from Sanofi Sa